Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

The role of human tissue kallikreins 7 and 8 in intracranial malignancies.

Prezas P, Scorilas A, Yfanti C, Viktorov P, Agnanti N, Diamandis E, Talieri M.

Biol Chem. 2006 Dec;387(12):1607-12.

PMID:
17132107
2.

Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.

Shan SJ, Scorilas A, Katsaros D, Rigault de la Longrais I, Massobrio M, Diamandis EP.

Clin Chem. 2006 Oct;52(10):1879-86. Epub 2006 Aug 17.

3.

Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.

Talieri M, Mathioudaki K, Prezas P, Alexopoulou DK, Diamandis EP, Xynopoulos D, Ardavanis A, Arnogiannaki N, Scorilas A.

Thromb Haemost. 2009 Apr;101(4):741-7.

PMID:
19350120
4.

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.

Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Kr├╝ger A, Magdolen V.

Biol Chem. 2006 Jun;387(6):807-11.

PMID:
16800744
5.

Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness.

Sher YP, Chou CC, Chou RH, Wu HM, Wayne Chang WS, Chen CH, Yang PC, Wu CW, Yu CL, Peck K.

Cancer Res. 2006 Dec 15;66(24):11763-70.

6.

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.

Johnson SK, Ramani VC, Hennings L, Haun RS.

Cancer. 2007 May 1;109(9):1811-20.

7.

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.

Ramani VC, Hennings L, Haun RS.

BMC Cancer. 2008 Dec 17;8:373. doi: 10.1186/1471-2407-8-373.

8.

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.

Planque C, Li L, Zheng Y, Soosaipillai A, Reckamp K, Chia D, Diamandis EP, Goodglick L.

Clin Cancer Res. 2008 Mar 1;14(5):1355-62. doi: 10.1158/1078-0432.CCR-07-4117.

9.

Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.

Kountourakis P, Psyrri A, Scorilas A, Markakis S, Kowalski D, Camp RL, Diamandis EP, Dimopoulos MA.

Thromb Haemost. 2009 Mar;101(3):541-6.

PMID:
19277417
10.

Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.

Li X, Liu J, Wang Y, Zhang L, Ning L, Feng Y.

Cancer Sci. 2009 Apr;100(4):601-7. doi: 10.1111/j.1349-7006.2009.01090.x.

11.

Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins.

Kishibe M, Bando Y, Terayama R, Namikawa K, Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Jiang YP, Mitrovic B, Perez D, Iizuka H, Yoshida S.

J Biol Chem. 2007 Feb 23;282(8):5834-41. Epub 2006 Dec 19.

12.

Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.

Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H.

Cancer. 2007 Jul 1;110(1):215-23.

13.

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.

Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, Takehara K, Diamandis EP.

Br J Dermatol. 2005 Aug;153(2):274-81.

PMID:
16086736
14.

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

Breast Cancer Res. 2007;9(6):R76.

15.

Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro.

Dong PX, Jia N, Xu ZJ, Liu YT, Li DJ, Feng YJ.

J Exp Clin Cancer Res. 2008 Nov 27;27:77. doi: 10.1186/1756-9966-27-77.

16.
17.

Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.

Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K, Scorilas A.

Thromb Haemost. 2004 Jan;91(1):180-6.

PMID:
14691584
18.

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.

Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.

Breast Cancer Res. 2009;11(1):R1. doi: 10.1186/bcr2215. Epub 2009 Jan 5.

19.

The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.

Wang P, Wu X, Chen W, Liu J, Wang X.

Gynecol Oncol. 2007 Mar;104(3):714-20. Epub 2007 Jan 3.

PMID:
17204312
20.

Human tissue kallikreins: a new enzymatic cascade pathway?

Yousef GM, Diamandis EP.

Biol Chem. 2002 Jul-Aug;383(7-8):1045-57. Review.

PMID:
12437087

Supplemental Content

Support Center